Oman Chlorine SAOG

Oman Chlorine SAOG has a debt-to-equity ratio of 2.08, indicating a capital structure that is significantly leveraged, with long-term debt accounting for 492.27 million OMR of its 675.09 million OMR total liabilities. The company's current ratio of 0.82 suggests it has less current assets than current liabilities, raising concerns about short-term liquidity. Free cash flow of 898,000 OMR in the latest period is modest, and capital expenditures of -466,000 OMR suggest a reduction in investment in physical assets.

Profitability metrics show a return on equity of 1.27% and a return on assets of 0.33%, both of which are below the typical thresholds for healthy performance in the Commodity Chemicals industry. The company's operating margin is 16.42% (1.277 million OMR operating income on 7.788 million OMR revenue), which is relatively low for a chemical producer, indicating potential cost pressures or pricing constraints.

The company's revenue is concentrated in a single business segment and geographic region, with no disclosed diversification across products or markets. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in the Middle East.

Growth trajectory appears muted, with no disclosed revenue growth in the latest period and no forward-looking guidance provided in the available data. The company's capital expenditures have declined, and there is no indication of new product lines or market expansion in the near term.

Risk factors include a high debt load and weak liquidity, with net cash being negative after subtracting total debt. The company has a low dilution risk, with no recent share issuance or shelf registration activity reported. No material risk factors were disclosed in the latest filings, but the leverage profile suggests a need for close monitoring of interest rates and debt serviceability.

No recent events, such as earnings calls, regulatory filings, or press releases, were disclosed in the available data to indicate strategic shifts or operational changes.

Cash conversion of 15.46 is best-in-class, vastly outperforming the 1.1 cohort median for commodity chemicals companies.

Revenue demonstrated an 8.3% compound annual growth rate over the four-year period ending in FY0.

The company maintains a positive net margin of 3.9%, ensuring profitability despite recent revenue declines.

Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value.

Debt-to-equity ratio of 2.08 is in the bottom quartile, indicating significantly higher leverage than the 0.31 cohort median.

Credit risk is flagged as high, reflecting substantial concerns regarding the company's ability to meet debt obligations.

Return on equity of 1.27% lags the 3.61% cohort median, indicating inefficient use of shareholder capital.